|
|
||||||||
Ann Thorac Surg 2007;83:661-662
© 2007 The Society of Thoracic Surgeons
a Department of Cardiovascular Surgery, Saitama Medical Center, Saitama, Japan
b Department of Cardiovascular Surgery, Saitama Medical School, Saitama, Japan
c Department of Cardiology, Saitama Medical School, Saitama, Japan
d Department of Hematology, Saitama Medical School, Saitama, Japan
e Department of Transfusion and Cell Therapy, Saitama Medical School, Saitama, Japan
Accepted for publication June 23, 2006.
* Address correspondence to Dr Gojo, Department of Cardiovascular Surgery, Saitama Medical Center 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan. (Email: satoshi{at}saitama-med.ac.jp).
We describe a novel therapy of mononuclear cell transplantation combined with a left ventricular assist device (LVAD) for severe ischemic heart failure. Significant myocardial recovery by the LVAD rarely occurs in the severely failing heart. We undertook successful mononuclear cell transplantation in a patient who sustained an acute myocardial infarction that had resulted in the LVAD therapy. The heart regained good function after cell transplantation, and the LVAD was explanted 6 weeks later. These results suggest that this novel therapy could be an alternative to cardiac transplantation for severe ischemic heart failure.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |